Converge
Highly Engaged Employees
Highly Engaged EmployeesBusiness Services · Delaware, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
108 W 13th St Ste 100, Wilmington, Delaw...Website
www.converge-bio.comRevenue
$11.5 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
2
1
1
About Converge
Converge is at the forefront of integrating Generative AI with biological data, transforming drug discovery and development. By harnessing the power of Large Language Models (LLMs) trained on the unique syntax of biological systems, we empower biotech and pharmaceutical companies to predict biological outcomes, contextualize them with deeper insights, and generate novel molecular candidates. These models transcend traditional computational methods, offering enhanced understanding of complex molecular interactions, signaling pathways, and disease mechanisms. This enables researchers to anticipate how compounds may interact with biological targets, accelerating the identification of promising drug candidates.Explore more
Converge Org Chart
Get the full picture
Sign in to uncover key details.
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Converge your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check out if Converge is spiking on competitors!
Funding: Get notified immidiatlly once Converge has new funding data
Product Launch: Get notified when Converge launches new products
Congratulate Masked Content for being promoted to Masked Content at Converge
Click to see if Converge had a recent Job posting/layoffs
Check if Converge has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Converge, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Converge recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Converge as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Converge is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Converge is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Converge.
Converge financials insights
Gather financial insights about Converge, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$5.5M
2026
Series A
$25M
Grant
$2.5M
Converge Tech Stack
A closer look at the technologies used by Converge
See more technologies
Most Recent Scoops
Funding
Funding
Hiring Plans
Converge has more open roles in Engineering & Technical than it has had at any time in the past 12 months.
Hiring Plans
Funding
Funding
Funding
Converge News & Media
Converge Bio uses ConvergeAB to improve popular cancer treatment with a single prompt
The findings, which led to a provisional patent filing, suggest Converge Bio improved cetuximab bindings to the receptor, achieving 2x higher affinity using a single AI prompt, strengthening its ability to block cancer-driving signals in colorectal, head, and neck cancers BOSTON and TEL...Purple Biotech Announces AI Collaboration with Converge Bio to Accelerate Development of its Next-Generation Tri-Specific Antibody Platform
Collaboration leverages Converge Bio's proprietary generative AI to design and optimize novel tri-specific antibodies for oncology needsConverge Bio raises $25M to bring generative AI drug discovery to every biotech and pharmaceutical company
Led by Bessemer Venture Partners, the highly oversubscribed round comes 18 months after founding, following strong commercial traction and scientific results BOSTON, Jan. 13, 2026 /PRNewswire/ -- Converge Bio, the AI platform for accelerated drug discovery and development, announced today...Converge Bio raises $25M, backed by Bessemer and execs from Meta, OpenAI, Wiz
AI drug discovery startup Converge Bio raised $25 million in a Series A led by Bessemer Venture Partners, with additional backing from executives at Meta, OpenAI, and Wiz.
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Converge
Sign Up For FreeTo access detailed company insights
Converge is at the forefront of integrating Generative AI with biological data, transforming drug discovery and development. By harnessing the power of Large Language Models (LLMs) trained on the unique syntax of biological systems, we empower biotech and pharmaceutical companies to predict biological outcomes, contextualize them with deeper insigh... Read More
